Anavex Life Sciences (NASDAQ:AVXL)

Anavex Life Sciences (NASDAQ:AVXL)


Share Price
$ 3.56
Change
-0.035 (-0.97 %)
Market Cap
$174.85 m
Proactive Investors - Run By Investors For Investors

Anavex Life Sciences

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company engaged in the development of novel drug candidates to treat Alzheimer’s disease, other CNS diseases and various types of cancer.

EPIC: AVXL
Market: NASDAQ:AVXL
52-week High/Low: $4.35 / $1.25
Sector: Pharmaceuticals
Market Cap: $174.85 m
Website: www.anavex.com
col 3
col 4
col 5
col 6

Anavex Life Sciences Timeline

Video RSS

Videos

VIEW ALL VIDEOS
Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use